%0 Journal Article
%T A Cost-Effectiveness Model for Adjunctive Smoked Cannabis in the Treatment of Chronic Neuropathic Pain
%A Brandon K. Bellows
%A David J. Grelotti
%A Griffin A. Tyree
%A Igor Grant
%A James D. Murphy
%A Joseph Hampton Atkinson
%A Mark S. Wallace
%A Reith Sarkar
%A Ronald J. Ellis
%A Thomas D. Marcotte
%A Yuyan Shi
%J Archive of "Cannabis and Cannabinoid Research".
%D 2019
%R 10.1089/can.2018.0027
%X Background: A recent meta-analysis affirmed the benefit of medicinal cannabis for chronic neuropathic pain, a disabling and difficult-to-treat condition. As medicinal cannabis use is becoming increasingly prevalent among Americans, an exploration of its economic feasibility is warranted. We present this cost-effectiveness analysis of adjunctive cannabis pharmacotherapy for chronic peripheral neuropathy
%K cost-effectiveness
%K medical marijuana
%K painful neuropathy
%K diabetic neuropathy
%K HIV neuropathy
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446169/